Center for Translational Research Featured in Drug Discovery News
An article in the May issue of Drug Discovery News features CHI's Center for Translational Research (CTR), Towson, MD, and Jeffrey Otto, national director of the CTR. The article, "Forging an Oncology Collaboration," discusses how CHI and Caliper Life Sciences Inc. are working together to develop methods to evaluate and predict the effectiveness of new cancer drugs. The CTR will provide human tumor samples to Caliper, which will use the samples to perform biomarker, drug resistance and drug sensitivity studies. The entire May 2011 issue, including "Forging an Oncology Collaboration" on page 17, can be viewed on the Drug Discovery News website.